The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
about
FGFR3-TACC3 fusion in solid tumors: mini reviewGenomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersIdentification of targetable FGFR gene fusions in diverse cancers.Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.A place for precision medicine in bladder cancer: targeting the FGFRs.Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number dataMiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinomaClinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases.Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.The Fibroblast Growth Factor signaling pathwayDisruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer.Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway.Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomasMolecularly targeted therapies in non-small-cell lung cancer annual update 2014Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers.Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.Comparative transcriptomics reveals similarities and differences between astrocytoma grades.EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinomaDevelopment of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE SamplesChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data.Landscape of gene fusions in epithelial cancers: seq and ye shall find.Multiple functions of a glioblastoma fusion oncogene.Fusion genes and their discovery using high throughput sequencing.Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non-small cell lung cancer.Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatmentTranslational genomics in cancer research: converting profiles into personalized cancer medicineTyrosine kinase gene rearrangements in epithelial malignancies.TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosisFGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling.TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitorsFGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients.Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.
P2860
Q26740578-986A1738-1CEC-4AE7-96CF-3D9AD7D31D25Q26998790-CCA07367-289C-4986-87A3-B60F31FB08F9Q26998955-ABB1EB6C-CF44-47DE-875E-C13B28164269Q27852147-0DD5727C-6AFB-439D-9270-E3A1444CFCEBQ27853175-8CB41519-D8CC-4879-8DA4-F2AFD992067AQ30249143-F4044C6C-187A-4EF8-9A46-E79766BE41E8Q30405560-5DE9B861-4229-4D87-85C8-9D17348B6B98Q30699293-940F2FCC-6DD8-42DF-ADBC-59DAA34481E2Q33609359-650EA9F5-5F45-4FA0-98B0-33FE6C92BF80Q33634701-0B6E6BEB-4427-49AD-B494-848FA36F598DQ33774682-B30A7A41-2414-41C1-81C1-D104AE62E8F1Q33815218-2DCF3CC5-26F2-49B7-8591-0981443C0DABQ34340295-856544AF-FBBF-4B12-9938-08DDAD54AB1EQ34381578-1183785B-6A9F-4A47-A1FD-409CE7572EEFQ34439333-8E40E610-4119-4F2F-81BA-5CA5020A938FQ34467171-9997F10D-05A6-4CFD-B077-A7AC9E5F3B60Q34469351-0FC44136-7D09-46CF-9FD5-755F3580DFF0Q34662199-3E90AB19-CAD9-4EE4-A30E-CE6DB51A6A79Q35008028-90104E47-DB96-4429-8BAD-175367E60D8AQ35136424-8632D907-E68A-4110-9638-E280AB265E03Q35741587-ECDB1AC2-CFB2-456B-8D3D-CB9973EFD73FQ35862636-BC5D7EA8-8AA4-47CC-A1B1-A67B9372EBC8Q35870174-4CC700D3-8D5D-448C-8878-45C54D9C8B36Q36172699-86C0E8CA-136F-427F-9964-C67AEA346C43Q36211300-6A00DE4B-037C-468A-A3BB-7E7E973EE6E5Q36215971-63A76384-AA04-4475-9B44-64287F4D5336Q36363386-7FB79A7D-F579-40D0-B186-D4DBC82D10DBQ36383369-E0B521A5-80E4-4B02-BE01-4C76567188A2Q36580465-4F319691-1F35-4A88-A455-7D95013F8966Q36909126-E47CA177-D23F-4F59-B1C5-8DE201F1FC5CQ37269061-23ADF807-1830-4C13-B38A-BFE696B32569Q37346563-719A1BA6-D2D4-4261-9BBD-474312484DE2Q37353937-D5534655-6E3C-4993-BF98-EBD079A43D62Q37386249-A3D95D10-0726-4EDC-BED1-FD7367BB7AA2Q37515966-FBDCB8FA-C0FD-494C-BE64-6FAA73F2F1B2Q37520384-8275C7D8-E692-4143-8A43-E8B198B30127Q37622191-F15550FC-28B2-41F5-870C-4A58293DC0FBQ37688959-36ADBC82-CA3B-4D7F-B01C-4D68499F4FBAQ37708987-69F643D0-97F8-4991-B0E3-2606B23A6D02Q37729676-EA31F63D-14B1-4600-99DC-165E008346D3
P2860
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
@ast
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
@en
type
label
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
@ast
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
@en
prefLabel
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
@ast
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
@en
P2093
P2860
P50
P356
P1476
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
@en
P2093
Brittany C Parker
Chang-Gong Liu
David E Cogdell
Frederick F Lang
Hannu Haapasalo
Hong Zheng
Kexin Chen
Kirsi J Granberg
P2860
P304
P356
10.1172/JCI67144
P407
P577
2013-01-09T00:00:00Z